检索

标题
作者
Evaluation of the efficacy of pembrolizumab in patients with metastatic cervical cancer depending on the value of the neutrophil-lymphocyte index
Orlova R., Gorkina Y.
PARP inhibitors in a personalized approach to the treatment of castration-resistant prostate cancer: clinical case
Gritskevich A., Byteman T., Monakov D., Rusakov I., Mishugin S.
Experience of the use of ixabepilone in polychemotherapy regimens for disseminated triple-negative breast cancer
Glazkova E., Frolova M., Menshikov S., Stenina M.
CYCLIN-DEPENDENT KINASE INHIBITORS - NEW THERAPEUTIC OPTION FOR PATIENTS WITH HORMONE-DEPENDENT HER2-NEGATIVE BREAST CANCER: CLINICAL EXPERIENCE
Sakaev D., Iskhakova A., Kunafina R.
NOVYY REZhIM PERVOY LINII KhIMIOTERAPII METASTATIChESKOGO KOLOREKTAL'NOGO RAKA
Darenskaya A., Dobrova N.
SUNITINIB (SUTENT) V PERVOY LINII LEChENIYa METASTATIChESKOGO RAKA POChKI
Gutorov S., Borisova E., Lichinitser M.
The role of alpelisib in the treatment of PIK3CA - a mutated breast cancer
Semiglazov V., Krivorotko P., Komyakhov A., Semiglazova T., Gigolaeva L., Tabagua T., Kazantseva M., Tergoeva A., Ulrikh D., Chervyak M., Klimenko V., Amirov N., Zhiltsova E., Semiglazov V.
Oral chemotherapy with vinorelbine for advanced breast cancer: its role in clinical practice
Sakaeva D., Nasretdinov A.
RESOLUTION SUMMARIZING THE RESULTS OF THE EXPERT COUNCIL "MODERN APPROACHES TO THE TREATMENT OF HER2-NEGATIVE METASTATIC BREAST CANCER. PROSPECTS FOR THE USE OF ERIBULIN AS A PART OF COMBINATION THERAPY FOR BREAST CANCER"
Artamonova E., Bolotina L., Gligorov Z., Zhukov N., Zhukova L., Imyanitov E., Karabina E., Kovalenko E., Lichinitser M., Manzyuk L., Semiglazov V., Semiglazova T., Stroyakovsky D.
Eribulin – novyy mikrotrubochkovyy ingibitor dlya lecheniya metastaticheskogo raka molochnoy zhelezy
Stenina M.
Will our clinical practice change with the availability of new diagnostic methods, drug therapy and assessment of its effectiveness? Clinical case: hormone receptor-positive, HER2-negative metastatic breast cancer
Konstantinova M., Kuzina L.
Modern immunotherapy for kidney cancer
Protsenko S., Semenova А., Oganesyan A., Anokhina E., Novik A.
CLINICAL CASE OF SUCCESSFUL TREATMENT OF METASTATIC COLORECTAL CANCER WITH ACHIEVEMENT OF COMPLETE PATHOMORPHOLOGICAL RESPONSE (FIRST LINE CHEMOTHERAPY)
Darenskaya A., Dobrova N., Zhukova L., Medvedeva B., Mochalnikova V.
KONVERSIONNAYa I NEOAD\"YuVANTNAYa TERAPIYa PRI METASTAZAKh KOLOREKTAL'NOGO RAKA V PEChEN'
Sekacheva M.
Olaparib -modern approach to the treatment of BRCA-associated HER2-negative metastatic breast cancer. Clinical experience
Lubennikova E., Zhukova L., Gordeeva O., Drobot N., Kuznetsov A., Ganshina I.
Trastuzumab emtanzin in the treatment of HER2-positive metastatic breast cancer in patients with visceral crisis
Vladimirova L., Popova I., Abramova N., Storozhakova A., Tikhanovskaya N., Novoselova K., Lyanova A., Ryadinskaya L., Yezhova M., Teplyakov M.
LONG-TERM RESULTS OF SECOND LINE ANTICANCER THERAPY OF METASTATIC COLORECTAL CANCER AND THEIR RELATIONSHIP WITH CLINICAL AND MORPHOLOGICAL CHARACTERISTICS
Vorontsova K., Chemoglazova E., Rotobelskaya L., Vyshinskaya G.
NOVYE VOZMOZhNOSTI TERAPII BOL'NYKh METASTATIChESKIM RAKOM MOLOChNOY ZhELEZY, POLUChAVShIKh RANEE ANTRATsIKLINI TAKSAN-SODERZhAShchUYu KhIMIOTERAPIYu: OBZOR LITERATURY I KLINIChESKIY SLUChAY
Zhukova L.
Dynamics of indicators of systemic and local immunity during treatment in patients with gastric cancer
Khakimova G., Tryakin A., Zabotina T.
The use of ramukirumab in the treatment of metastatic gastric cancer in real clinical practice
Belyak N., Kutukova S., Orlova R., Zhukova N., Erdniev S., Zorina E., Avramenko I., Antimonik N., Popova N., Ivanova A., Androsova A.
Sovremennye vozmozhnosti lecheniya bol'nykh disseminirovannym kolorektal'nym rakom: II liniya lekarstvennoy terapii -
Vorontsova K., Dobrova N., Vyshinskaya G.
Chemotherapy of anthracy-clineand taxan-resistant breast cancer
Kovalenko E., Satirova E., Artamonova E., Manzyuk L.
Abemacyclib is a unique representative of the class of CDK4/6 inhibitors in the treatment of HR+/HER2- metastatic breast cancer
Grechukhina K., Vorontsova K., Kuko T., Prosvirnov A., Ganshina I., Lubennikova E., Kolyadina I., Zhukova L.
Efficacy and safety of therapy with biosimilar bevacizumab in the treatment of patients with metastatic colon cancer -a series of clinical observations
Fedyanin M., Elsnukaeva K., Pokataev I., Sekhina O., Chekini D., Bulanov A., Tryakin A., Tyulyandin S.
Opyt primeneniya monoklonal'nykh antitel - blokatorov EGFR v lechenii metastaticheskogo kolorektal'nogo raka
Abramova N., Storozhakova A., Kalabanova E., Kabanov S., Popova I., Novoselova K., Tikhanovskaya N., Agieva A., Snezhko T., Samaneva N., Kit O., Vladimirova L.
SEARCH FOR MARKERS OF EFFICIENCY OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
Gutorov S., Borisova E., Chichikov E., Denisenko A., Borisova Y., Chichikov Y., Denisenko A., Gutorov S.
The use of panitumumab in the treatment of chemoresistant metastatic sigmoid colon adenocarcinoma: a clinical case
Protsenko S., Teletaeva G., Degtyareva E., Semenova A., Latipova D., Novik A.
PROGNOSTIC SIGNIFICANCE OF THE E-CADHERIN EXPRESSION LEVEL IN PRIMARY TUMORS OF THE COLON IN PATIENTS WITH METASTATIC COLORECTAL CANCER, RECEIVED NEW CHEMOTHERAPY REGIMEN BASED ON TRIPLE COMBINATION: IRINOTECAN+OXALIPLATIN+CONTINUOUS-INFUSION 5-FLUOROURACIL AS A FIRST-LINE TREATMENT
Darenskaya A., Dobrova N., Khochenkov D., Stepanova E.
Klinicheskiy sluchay uspeshnogo lecheniya erilibulinom metastaticheskogo raka molochnoy zhelezy
Limareva S., Laytsan K., Stroyakovskiy D., Demidova I., Gorbunova V.
XELODA IN THE TREATMENT OF METASTATIC COLORECTAL CANCER
Dobrova N., Dobrova N.
Algorithm for diagnostics and systemic therapy of metastatic hormone-sensitive HER2-negative breast cancer
Dashyan G., Olchonova A., Dzhelyalov E., Akhmedov R., Sereda O., Vats A., Zhurov A., Shaikhelislamova L., Pushkaruk G., Belousov A.
Potentials for the use of aflibercept in the treatment of patients with metastatic colorectal cancer
Vladimirova L., Abramova N., Popova I., Storozhakova A., Novoselova K., Tikhanovskaya N., Ryadinskaya L., Lyanova A., Myagkova V., Teplyakova M., Kabanov S., Kalabanova E., Samaneva N., Tishina A., Strakhova L., Yezhova M.
MODERN APPROACHES TO THE CHOICE OF THERAPY OF LOCALLY ADVANCED AND RECURRENT/ METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA: WHAT IS THE BASIS FOR THE CHOICE OF THERAPY IN CLINICAL PRACTICE?
Kutukova S.
Perspektivy primeneniya kapsul vinorelbina v sovremennoy onkologii
Gutorov S., Stepanchenko M., Lichinitser M.
PERVAYa LINIYa TERAPII METASTATIChESKOGO RAKA POChKI
Timofeev I.
1 - 35 的 35 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语